KKR Invests in Avantus to Support Renewable Energy Deployment in the United States
Transaction Marks First U.S. Investment from KKR’s Global Climate Strategy NEW YORK–(BUSINESS WIRE)–Today, KKR, a leading global investment firm, announced... Read more.
Bristol Myers Squibb’s Abecma (idecabtagene vicleucel) Becomes First CAR T Cell Therapy Approved in the European Union in Earlier Lines for Triple-Class Exposed Relapsed and Refractory Multiple Myeloma
Abecma demonstrated superiority over standard regimens in the Phase 3 KarMMa-3 trial, with a 51% reduction in risk of disease progression or death and a well-established... Read more.
Nortech Systems Reports Fourth Quarter and Full Year 2023 Results
Full Year Net Sales Up Nearly 4% from Prior Year; Gross Margin Increase 130 Basis Points from Prior Year EBITDA Increases to $8.0 million, Up 38.2% from Prior Year... Read more.
Nutanix Files Theft of Intellectual Property Lawsuit Against Tessell, Inc.
Nutanix asserts willful copyright and patent infringement, including theft of Nutanix resources and its database service source code SAN JOSE, Calif.–(BUSINESS... Read more.
Alpha Cognition to Present at the Emerging Growth Conference on April 3, 2024 at 12:00pm EDT.
VANCOUVER, British Columbia–(BUSINESS WIRE)–Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF), a biopharmaceutical company developing novel therapeutics... Read more.
Corporacion America Airports Reports Fourth Quarter and Full Year 2023 Results
Passenger traffic up 13% YoY reaching 99.1% of 4Q19 pre-pandemic levels Consolidated Revenues, ex-IFRIC12 and ex-IAS29, up 19% YoY and 37% above 4Q19 Adjusted EBITDA... Read more.
Air Lease Corporation Announces Lease Placement of Two New Airbus A321neo Aircraft with Transavia
LOS ANGELES–(BUSINESS WIRE)–Today Air Lease Corporation (NYSE: AL) announced long-term lease agreements for two new Airbus A321-200neo aircraft with... Read more.
Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative... Read more.
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024
DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform... Read more.
Media Advisory: Federal Home Loan Bank of Dallas and Wells Fargo Bank Award $1.5M for Senior Housing
***1:30 p.m., Thursday, March 21, 1301 Stephanie Road SE, Rio Rancho, NM, 87124 *** RIO RANCHO, N.M.–(BUSINESS WIRE)–The Federal Home Loan Bank of Dallas... Read more.